Or Refractory B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Or Refractory B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Phase I Clinical Study on the Safety and Efficacy of CY-219 CAR-T Cell Injection in the Treatment of Relapsed/Refractory B-Cell Lymphoma [Phase 1]
Phase I clinical trial evaluating CY-219 CAR-T cell therapy for relapsed/refractory B-cell lymphoma; not yet recruiting.
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma [Phase 4]
This document reports a Phase 4 clinical trial update for a secondary infusion of Relma-cel in relapsed or refractory B-cell lymphoma, curre…
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma [Phase 1]
Phase 1 clinical trial evaluating L218CAR19 in relapsed or refractory B-cell lymphoma, currently recruiting.